Arch Therapeutics Stock Price, News & Analysis
Company Description
Arch Therapeutics (OTC: ARTH) is a publicly traded surgical and medical instrument manufacturing company in the Manufacturing sector.
ARTH stock has declined 86.4% over the past year. Shares last traded at $0.1608.
This page provides a comprehensive overview of ARTH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Arch Therapeutics (ARTH) stock last traded at $0.1608. Over the past 12 months, the stock has lost 86.4%.
Latest News
Arch Therapeutics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences. View all ARTH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Arch Therapeutics (ARTH) currently stands at 6.6 thousand shares, down 55.8% from the previous reporting period, representing 0.2% of the float. Over the past 12 months, short interest has decreased by 55.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Arch Therapeutics (ARTH) currently stands at 1.0 days, down 88.1% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 88.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 8.4 days.
ARTH Company Profile & Sector Positioning
Arch Therapeutics (ARTH) operates in the Surgical and Medical Instrument Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.